Skip to main content

Table 1 Characteristics according to cognitive status

From: Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study

Variables

T2D-NCF group

T2D-MCI group

P valuea

Low folate

(< 7.0 μg/L)

(n = 23)

High folate (≥7.0 μg/L)

(n = 40)

Total

(n = 63)

Low folate

(< 7.0 μg/L)

(n = 38)

High folate

(≥7.0 μg/L)

(n = 25)

Total

(n = 63)

Sex

 Men

9 (39.1)

13 (32.5)

22 (34.9)

17 (44.7)

5 (20.0)

22 (34.9)

> 0.999

 Women

14 (60.9)

27 (67.5)

41 (65.1)

21 (55.3)

20 (80.0)

41 (65.1)

 

Education

 No education

5 (21.7)

8 (20.0)

13 (20.6)

7 (18.4)

6 (24.0)

13 (20.6)

> 0.999

 1–6 years

5 (21.8)

10 (25.0)

15 (23.8)

10 (26.3)

5 (20.0)

15 (23.8)

 

 ≥6 years

13 (56.5)

22 (55.0)

35 (55.6)

21 (55.3)

14 (56.0)

35 (55.6)

 

Age (years)

73.70 ± 3.10

74.28 ± 4.78

74.06 ± 4.22

74.55 ± 4.17

74.84 ± 5.01

74.67 ± 4.48

0.148

MMSE

26.65 ± 2.89

26.80 ± 2.84

26.75 ± 2.84

20.68 ± 3.99

19.92 ± 3.73

20.38 ± 3.68

< 0.001

ADL

21.30 ± 1.85

22.13 ± 2.96

21.83 ± 2.62

22.24 ± 3.22

23.00 ± 3.35

22.54 ± 3.27

0.217

Smoking status

 Yes

10 (43.5)

11 (27.5)

21 (33.3)

17 (44.7)

8 (32.0)

25 (39.7)

0.459

 No

13 (56.5)

29 (72.5)

42 (66.7)

21 (55.3)

17 (68.0)

38 (60.3)

 

Drinking status

 Yes

5 (21.7)

9 (22.5)

14 (22.2)

7 (18.4)

3 (12.0)

10 (15.9)

0.364

 No

18 (78.3)

31 (77.5)

49 (77.8)

31 (81.6)

22 (88.0)

53 (84.1)

 

Body mass index (kg/m2)

26.03 ± 3.78

25.71 ± 2.85

25.82 ± 3.19

26.41 ± 3.99

26.43 ± 4.07

26.42 ± 4.00

0.377

Body mass index

 < 24.0 kg/m2

7 (30.4)

11 (27.5)

18 (28.6)

10 (26.3)

9 (36.0)

19 (30.2)

0.749

 24.0–28.0 kg/m2

8 (34.8)

19 (47.5)

27 (42.8)

16 (42.1)

7 (28.0)

23 (36.5)

 

 ≥28.0 kg/m2

8 (34.8)

10 (25.0)

18 (28.6)

12 (31.6)

9 (36.0)

21 (33.3)

 

Systolic blood pressure (mmHg)

137.17 ± 16.98

131.13 ± 18.86

133.33 ± 18.29

136.71 ± 16.78

131.20 ± 11.75

134.52 ± 15.13

0.677

Diastolic blood pressure (mmHg)

76.96 ± 10.53

73.88 ± 8.59

75.00 ± 9.38

77.24 ± 8.60

74.40 ± 6.67

76.11 ± 7.95

0.475

Diabetes Duration (years)

15.0 (8.0, 20.0)

16.0 (9.3, 21.5)

16.0 (9.0, 20.0)

14.5 (9.0, 20.0)

15.0 (10.0, 22.0)

15.0 (9.0, 20.0)

0.833

Anti-diabetic medications

 OHAs

7 (30.4)

10 (25.0)

17 (27.0)

7 (18.4)

7 (28.0)

14 (22.2)

0.799

 Insulin

5 (21.7)

8 (20.0)

13 (20.6)

10 (26.3)

5 (20.0)

15 (23.8)

 

 Insulin + OHAs

11 (47.8)

22 (55.0)

33 (52.4)

21 (55.3)

13 (52.0)

34 (54.0)

 

Triglycerides (mmol/L)

1.27 (0.98, 1.94)

1.33 (0.97, 2.18)

1.32 (0.98, 2.01)

1.75 (1.14, 2.22)

1.43 (1.19, 2.48)

1.71 (1.15, 2.28)

0.135

Total cholesterol (mmol/L)

5.06 ± 0.99

4.97 ± 1.03

5.00 ± 1.00

5.27 ± 1.19

5.73 ± 0.91

5.45 ± 1.10

0.013

HDL-C (mmol/L)

1.41 ± 0.40

1.39 ± 0.32

1.40 ± 0.35

1.31 ± 0.27

1.42 ± 0.30

1.36 ± 0.29

0.483

LDL-C (mmol/L)

 < 2.6 mmol/L

8 (34.8)

13 (32.5)

21 (33.3)

6 (15.8)

4 (16.0)

10 (15.9)

0.023

 ≥2.6 mmol/L

15 (65.2)

27 (67.5)

42 (66.7)

32 (84.2)

21 (84.0)

53 (84.1)

 

Fasting plasma glucose (mmol/L)

9.03 ± 3.53

7.80 ± 1.74

8.25 ± 2.59

8.62 ± 2.58

9.18 ± 3.00

8.74 ± 2.72

0.338

Glycated hemoglobin A1c (%)

8.70 ± 2.53

7.95 ± 1.51

8.22 ± 1.96

8.34 ± 2.02

9.19 ± 2.64

8.68 ± 2.31

0.220

 < 7.0%

5 (21.7)

14 (35.0)

19 (30.2)

6 (15.8)

4 (16.0)

10 (15.9)

0.057

 ≥7.0%

18 (78.3)

26 (65.0)

44 (69.8)

32 (84.2)

21 (84.0)

53 (84.1)

 

Hypertension

 Yes

19 (82.6)

23 (57.5)

42 (66.7)

28 (73.7)

18 (72.0)

48 (73.0)

0.437

 No

4 (17.4)

17 (42.5)

21 (33.3)

10 (26.3)

7 (28.0)

17 (27.0)

 

Diabetic retinopathy

 Yes

4 (17.4)

8 (20.0)

12 (19.0)

16 (42.1)

11 (44.0)

27 (42.9)

0.004

 No

19 (82.6)

32 (80.0)

51 (81.0)

22 (57.9)

14 (56.0)

36 (57.1)

 

Diabetic nephropathy

 Yes

4 (17.4)

8 (20.0)

12 (19.0)

15 (39.5)

11 (44.0)

26 (41.3)

0.007

 No

19 (82.6)

32 (80.0)

51 (81.0)

23 (60.5)

14 (56.0)

37 (58.7)

 
  1. Data are means ± standard deviation, median (inter-quartile range), or n (%)
  2. T2D-NCF Type 2 diabetes with normal cognitive function, T2D-MCI Type 2 diabetes with mild cognitive impairment, ADL Activities of daily living, MMSE Mini-mental state examination, OHAs Oral hypoglycemic agents, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol
  3. a P value was are significant difference between normal cognitive function group and mild cognitive impairment group